Suppr超能文献

通过理化参数评估类黄酮对人 DNA 拓扑异构酶 I 的抑制效力。

Potency of inhibition of human DNA topoisomerase I by flavones assessed through physicochemical parameters.

机构信息

Molécules de Communication et Adaptation des Microorganismes, Department RDDM, UMR 7245 CNRS/MNHN, Muséum National d'Histoire Naturelle, Paris, France.

出版信息

Free Radic Biol Med. 2011 Oct 1;51(7):1406-10. doi: 10.1016/j.freeradbiomed.2011.06.021. Epub 2011 Jun 23.

Abstract

DNA topoisomerases, enzymes involved in DNA replication and transcription, are known as targets for anticancer drugs. Among the various types of topoisomerase inhibitors, flavones (F) have been identified as promising compounds. In this study, it is shown that the potency of flavones acting as topoisomerase I inhibitors can be ranked according to their redox properties and their 3D structure. Linear correlations were observed between the topoisomerase I inhibition activity exerted by five flavones (chrysin, apigenin, kaempferol, fisetin, quercetin) and experimental and theoretical redox parameters of F. Moreover, theoretical calculations of the dihedral angle O(1)-2-1'-2' in the flavone molecules indicate the importance of their structural and steric features in their potency as topoisomerase I inhibitors. It is suggested that the flavones might interact with the DNA-topoisomerase I complex after their oxidation into quinones via autoxidation, enzymatic oxidation, or reactions with reactive oxygen species. Our investigation opens a new strategy quantitatively based on redox and 3D structural parameters in the search for the most active flavones as anticancer drug candidates inhibiting topoisomerase I.

摘要

DNA 拓扑异构酶是参与 DNA 复制和转录的酶,被认为是抗癌药物的靶点。在各种类型的拓扑异构酶抑制剂中,黄酮类化合物 (F) 已被确定为有前途的化合物。在这项研究中,表明作为拓扑异构酶 I 抑制剂的黄酮类化合物的效力可以根据它们的氧化还原性质和它们的 3D 结构进行排序。观察到五种黄酮类化合物(白杨素、芹菜素、山奈酚、非瑟酮、槲皮素)对拓扑异构酶 I 的抑制活性与 F 的实验和理论氧化还原参数之间存在线性相关性。此外,黄酮类分子中 O(1)-2-1'-2' 二面角的理论计算表明其结构和空间特征对其作为拓扑异构酶 I 抑制剂的效力的重要性。有人提出,黄酮类化合物可能在通过自动氧化、酶促氧化或与活性氧物种反应氧化成醌后,与 DNA-拓扑异构酶 I 复合物相互作用。我们的研究为通过氧化还原和 3D 结构参数定量寻找作为拓扑异构酶 I 抑制剂的最活跃的黄酮类化合物作为抗癌药物候选物开辟了一条新策略。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验